Literature DB >> 7049374

L-Asparaginase: discovery and development as a tumor-inhibitory agent.

J D Broome.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7049374

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  14 in total

1.  Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson.

Authors:  Kıvanç Birsoy; David M Sabatini; Richard Possemato
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  Reduction of acrylamide level through blanching with treatment by an extremely thermostable L-asparaginase during French fries processing.

Authors:  Shaohua Zuo; Tao Zhang; Bo Jiang; Wanmeng Mu
Journal:  Extremophiles       Date:  2015-06-16       Impact factor: 2.395

3.  Liposomal palmitoyl-L-asparaginase: characterization and biological activity.

Authors:  J C Jorge; R Perez-Soler; J G Morais; M E Cruz
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.

Authors:  Vassilios I Avramis; Eduard H Panosyan
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries.

Authors:  B K Albertsen; H Schrøder; P Jakobsen; H J Müller; N T Carlsen; K Schmiegelow
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 6.  L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.

Authors:  Rob Pieters; Stephen P Hunger; Joachim Boos; Carmelo Rizzari; Lewis Silverman; Andre Baruchel; Nicola Goekbuget; Martin Schrappe; Ching-Hon Pui
Journal:  Cancer       Date:  2010-09-07       Impact factor: 6.860

7.  L-asparaginase kills lymphoma cells by apoptosis.

Authors:  M D Story; D W Voehringer; L C Stephens; R E Meyn
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Biochemical characterization of a novel L-Asparaginase with low glutaminase activity from Rhizomucor miehei and its application in food safety and leukemia treatment.

Authors:  Linhua Huang; Yu Liu; Yan Sun; Qiaojuan Yan; Zhengqiang Jiang
Journal:  Appl Environ Microbiol       Date:  2013-12-20       Impact factor: 4.792

Review 9.  Targeting glucose metabolism in patients with cancer.

Authors:  Shannon E Elf; Jing Chen
Journal:  Cancer       Date:  2013-12-02       Impact factor: 6.860

Review 10.  Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias.

Authors:  Aboli Bhingarkar; Hima V Vangapandu; Sanjay Rathod; Keito Hoshitsuki; Christian A Fernandez
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.